NEW YORK (GenomeWeb News) – Epigenomics today said that it raised almost €5 million ($6.7 million) in a successful completion of a capital increase.

The increase was achieved through a rights issue and a subsequent private placement. As a result of the capital increase, Epigenomics said its cash runway has been extended to at least the fourth quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.